U.S. flag

An official website of the United States government, Department of Justice.

BJA FY 20 Nevada Prescription Monitoring Program Enhancement

Award Information

Award #
2020-PM-BX-0010
Location
Congressional District
Status
Open
Funding First Awarded
2021
Total funding (to date)
$781,761

Description of original award (Fiscal Year 2021, $781,761)

The Harold Rogers Prescription Drug Monitoring Program (PDMP) enhances the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized agency.

PDMPs help state and local governments to detect and prevent the diversion and abuse of pharmaceutically controlled substances such as opioids and other prescription drugs. The Harold Rogers PDMP strengthens states’ and territories’ ability to plan, implement, or enhance PDMPs by accommodating local decision-making based on state laws and preferences, while encouraging the replication of promising practices. In addition to supporting the implementation and enhancement of PDMPs, the program can support the Administration’s priority of tracking prescribing across providers and states through the integration of PDMPs and Electronic Health Records (EHRs) and Health Information Exchanges (HIEs) which are essential to promoting safe and responsible prescribing, while also assuring appropriate pain care.

The applicant will develop a training program that will be imbedded into the PMP to inform prescribers of the statutory requirements related to the PMP and its use, continue to track the percentage of Nevada prescribers who are registered and using the PMP, and further track and measure Nevada’s required use of the PMP database and its impact on Nevada’s mortality rate and incidents of emergency room visits due to prescription drug overdoses. In addition, the applicant will continue to track and measure the impact of Nevada’s new laws on Nevada’s rates of unlawful drug-seeking (“doctor shopping”) behaviors.

CA/NCF

Date Created: October 22, 2020